{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:52:34Z","timestamp":1790794354278,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00228-017-2273-8","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T14:39:52Z","timestamp":1496414392000},"page":"1149-1158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"73","author":[{"given":"Heidi","family":"Juntunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Taipale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"issue":"10","key":"2273_CR1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00228-008-0538-y","volume":"64","author":"S Shi","year":"2008","unstructured":"Shi S, Klotz U (2008) Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol 64(10):935\u2013951","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2273_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40266-014-0166-4","volume":"31","author":"GM Masclee","year":"2014","unstructured":"Masclee GM, Sturkenboom MC, Kuipers EJ (2014) A benefit-risk assessment of the use of proton pump inhibitors in the elderly. Drugs Aging 31(4):263\u2013282","journal-title":"Drugs Aging"},{"issue":"3","key":"2273_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bpg.2013.06.001","volume":"27","author":"C Reimer","year":"2013","unstructured":"Reimer C (2013) Safety of long-term PPI therapy. Best Pract res Clin Gastroenterol 27(3):443\u2013454","journal-title":"Best Pract res Clin Gastroenterol"},{"key":"2273_CR4","unstructured":"Canadian Institute for Health Information (2009) Proton pump inhibitor use in seniors: An analysis focusing on drug claims, 2001 to 2008. \nhttps:\/\/secure.cihi.ca\/free_products\/PPI_aib_en.pdf\n\n. Accessed 7th February 2017"},{"issue":"1","key":"2273_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/apt.13649","volume":"44","author":"PF Haastrup","year":"2016","unstructured":"Haastrup PF, Paulsen MS, Christensen RD, S\u00f8ndergaard J, Hansen JM, Jarb\u00f8l DE (2016) Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period. Aliment Pharmacol Ther 44(1):78\u201387","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"2273_CR6","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1111\/jgs.14528","volume":"64","author":"F Moriarty","year":"2016","unstructured":"Moriarty F, Bennett K, Cahir C, Fahey T (2016) Characterizing potentially inappropriate prescribing of proton pump inhibitors in older people in primary care in Ireland from 1997 to 2012. J am Geriatr Soc 64(12):e291\u2013e296","journal-title":"J am Geriatr Soc"},{"issue":"9","key":"2273_CR7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/pds.4043","volume":"25","author":"F Othman","year":"2016","unstructured":"Othman F, Card TR, Crooks CJ (2016) Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf 25(9):1079\u20131087","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"2273_CR8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/1756283X16650156","volume":"9","author":"A Potteg\u00e5rd","year":"2016","unstructured":"Potteg\u00e5rd A, Broe A, Hallas J, de Muckadell OB, Lassen AT, L\u00f8drup AB (2016) Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Therap Adv Gastroenterol 9(5):671\u2013678","journal-title":"Therap Adv Gastroenterol"},{"issue":"8","key":"2273_CR9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF03262283","volume":"29","author":"H Hamzat","year":"2012","unstructured":"Hamzat H, Sun H, Ford JC, MacLeod J, Soiza RL, Mangoni AA (2012) Inappropriate prescribing of proton pump inhibitors in older patients: effects of an educational strategy. Drugs Aging 29(8):681\u2013690","journal-title":"Drugs Aging"},{"issue":"2","key":"2273_CR10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.sapharm.2016.02.012","volume":"13","author":"PP Rane","year":"2017","unstructured":"Rane PP, Guha S, Chatterjee S, Aparasu RR (2017) Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US. Res Social Adm Pharm 13(2):358\u2013363","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"2273_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.4135","volume":"26","author":"SM Wallerstedt","year":"2017","unstructured":"Wallerstedt SM, Fastbom J, Linke J, Vitols S (2017) Long-term use of proton pump inhibitors and prevalence of disease- and drug-related reasons for gastroprotection\u2014a cross-sectional population based-study. Pharmacoepidemiol Drug Saf 26(1):9\u201316","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"2273_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57(1):6\u201314","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"2273_CR13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","volume":"43","author":"AL Sosa-Ortiz","year":"2012","unstructured":"Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ (2012) Epidemiology of dementias and Alzheimer\u2019s disease. Arch med res 43(8):600\u2013608","journal-title":"Arch med res"},{"issue":"5","key":"2273_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00406-014-0554-0","volume":"265","author":"B Haenisch","year":"2015","unstructured":"Haenisch B, von Holt K, Wiese B et al (2015) Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci 265(5):419\u2013428","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"2273_CR15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","volume":"73","author":"W Gomm","year":"2016","unstructured":"Gomm W, von Holt K, Thom\u00e9 F et al (2016) Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 73(4):410\u2013416","journal-title":"JAMA Neurol"},{"issue":"7","key":"2273_CR16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1017\/S1041610215002082","volume":"28","author":"A Booker","year":"2016","unstructured":"Booker A, Jacob LE, Rapp M, Bohlken J, Kostev K (2016) Risk factors for dementia diagnosis in German primary care practice. Int Psychogeriatr 28(7):1059\u20131065","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"2273_CR17","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1532-5415.2010.02819.x","volume":"58","author":"J Tjia","year":"2010","unstructured":"Tjia J, Rothman MR, Kiely DK, Shaffer ML, Holmes HM, Sachs GA, Mitchell SL (2010) Daily medication use in nursing home residents with advanced dementia. J am Geriatr Soc 58(5):880\u2013888","journal-title":"J am Geriatr Soc"},{"issue":"9","key":"2273_CR18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/pds.4026","volume":"25","author":"P Cojutti","year":"2016","unstructured":"Cojutti P, Arnoldo L, Cattani G, Brusaferro S, Pea F (2016) Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs? Pharmacoepidemiol Drug Saf 25(9):1070\u20131078","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"2273_CR19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/02813432.2010.493315","volume":"28","author":"M Teramura-Gr\u00f6nblad","year":"2010","unstructured":"Teramura-Gr\u00f6nblad M, Hosia-Randell H, Muurinen S, Pitk\u00e4l\u00e4 K (2010) Use of proton pump inhibitors and their associated risks among frail elderly nursing home residents. Scan J Prim Health Care 28(3):154\u2013159","journal-title":"Scan J Prim Health Care"},{"key":"2273_CR20","doi-asserted-by":"publisher","unstructured":"Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S (2016) Cohort profile: the Finnish medication and Alzheimer\u2019s disease (MEDALZ) study. BMJ Open. doi:\n10.1136\/bmjopen-2016-012100","DOI":"10.1136\/bmjopen-2016-012100"},{"issue":"7","key":"2273_CR21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"key":"2273_CR22","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC","edition":"4"},{"key":"2273_CR23","unstructured":"World Health Organization (2003) Introduction to Drug Utilization Research. pp 33\u201335. \nhttp:\/\/apps.who.int\/medicinedocs\/pdf\/s4876e\/s4876e.pdf\n\n. Accessed 14th December 2016"},{"key":"2273_CR24","doi-asserted-by":"publisher","unstructured":"Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J (2015) From prescription drug purchases to drug use periods\u2014a second generation method (PRE2DUP). BMC med Inform Decis Mak. doi:\n10.1186\/s12911-015-0140-z","DOI":"10.1186\/s12911-015-0140-z"},{"key":"2273_CR25","unstructured":"Finnish Medicines Agency Fimea (2015) National OTC medicines programme. Serial Publication Fimea Develops, Assess and Informs 1\/2015. \nhttp:\/\/www.fimea.fi\/documents\/160140\/765540\/28627_KAI_1_2015_EN.pdf\n\n. Accessed 4th January 2017"},{"key":"2273_CR26","unstructured":"Scarpignato C, Gatta L, Zullo A et al (2016) Effective and safe proton pump inhibitor therapy in acid-related diseases\u2014a position paper addressing benefits and potential harms of acid suppression. BMC Med. doi:0.1186\/s12916-016-0718-z"},{"key":"2273_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","volume":"37","author":"V Savarino","year":"2017","unstructured":"Savarino V, Dulbecco P, de Bortoli N, Ottonello A, Savarino E (2017) The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal. Eur J Intern Med 37:19\u201324","journal-title":"Eur J Intern Med"},{"issue":"6","key":"2273_CR28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.amjmed.2009.07.036","volume":"123","author":"CH Poh","year":"2010","unstructured":"Poh CH, Navarro-Rodriguez T, Fass R (2010) Review: treatment of gastroesophageal reflux disease in the elderly. Am J Med 123(6):496\u2013501","journal-title":"Am J Med"},{"issue":"7","key":"2273_CR29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/11537380-000000000-00000","volume":"27","author":"A Pilotto","year":"2010","unstructured":"Pilotto A, Franceschi M, Maggi S, Addante F, Sancarlo D (2010) Optimal management of peptic ulcer disease in the elderly. Drugs Aging 27(7):545\u2013558","journal-title":"Drugs Aging"},{"issue":"4","key":"2273_CR30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ejp.969","volume":"21","author":"A Hamina","year":"2017","unstructured":"Hamina A, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S (2017) Differences in analgesic use in community-dwelling persons with and without Alzheimer\u2019s disease. Eur J Pain 21(4):658\u2013667","journal-title":"Eur J Pain"},{"key":"2273_CR31","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ageing\/afs200","volume":"42","author":"British Geriatric Society","year":"2013","unstructured":"British Geriatric Society (2013) Guidance on the management of pain in older people. Age Aging 42:i1\u2013i57","journal-title":"Age Aging"},{"issue":"8","key":"2273_CR32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1532-5415.2009.02376.x","volume":"57","author":"American Geriatrics Society Panel on the pharmacological management of persistent pain in older persons","year":"2009","unstructured":"American Geriatrics Society Panel on the pharmacological management of persistent pain in older persons (2009) Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 57(8):1331\u20131346","journal-title":"J Am Geriatr Soc"},{"key":"2273_CR33","unstructured":"Finnish Medical Society Duodecim, Helsinki (2015) Current care: rheumatoid arthritis (in Finnish with English summary). \nhttp:\/\/www.kaypahoito.fi\/web\/kh\/suositukset\/suositus?id=hoi21010#s9_1\n\n. Accessed 31st March 2017"},{"key":"2273_CR34","doi-asserted-by":"publisher","unstructured":"Wedzicha JA, Miravitlles M, Hurst JR et al (2017) Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline. Eur Respir J. doi:\n10.1183\/13993003.00791-2016","DOI":"10.1183\/13993003.00791-2016"},{"key":"2273_CR35","unstructured":"Global Initiative for asthma (2017) Global strategy for asthma management and prevention (2017 update). \nhttp:\/\/ginasthma.org\/2017-gina-report-global-strategy-for-asthma-management-and-prevention\/\n\n. Accessed 31st March 2017"},{"issue":"4","key":"2273_CR36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0004563212473279","volume":"50","author":"CF Hughes","year":"2013","unstructured":"Hughes CF, Ward M, Hoey L, McNulty H (2013) Vitamin B12 and ageing: current issues and interaction with folate. Ann Clin Biochem 50(4):315\u2013329","journal-title":"Ann Clin Biochem"},{"issue":"11","key":"2273_CR37","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00228-007-0349-6","volume":"63","author":"J Haukka","year":"2007","unstructured":"Haukka J, Suvisaari J, Tuulio-Henriksson A, L\u00f6nnqvist J (2007) High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol 63(11):1069\u20131074","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2273_CR38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/11315960-000000000-00000","volume":"27","author":"M Rikala","year":"2010","unstructured":"Rikala M, Hartikainen S, Sulkava R, Korhonen MJ (2010) Validity of the Finnish prescription register for measuring psychotropic drug exposures among elderly Finns: a population-based intervention study. Drugs Aging 27(4):337\u2013349","journal-title":"Drugs Aging"},{"key":"2273_CR39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/CLEP.S116160","volume":"8","author":"H Taipale","year":"2016","unstructured":"Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S (2016) Agreement between PRE2DUP register data modelling method and comprehensive drug use interview among older persons. Clin Epidemiol 8:363\u2013371","journal-title":"Clin Epidemiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2273-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2273-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2273-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T11:58:48Z","timestamp":1502107128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2273-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["2273"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2273-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,2]]}}}